Literature DB >> 26690542

Ameliorative effects of β-sitosterol on some biochemical indices of hypertension in wistar albino rats.

C O Olaiya1, A M Esan1, T D Alabi2.   

Abstract

BACKGROUND: Cardiovascular diseases presently rank high as leading causes of death globally. The increasing acceptability of phytomedicine is due to the increasing inefficacy of many modern drugs used for the control of many diseases. The aim of this study was to investigate the ameliorative effects of β-sitosterol (BSS) in comparison with lisinopril, a standard antihypertensive drug, on certain biochemical hypertensive parameters in rats.
METHODS: Hypertension was induced with cadmium chloride and biochemical analysis of serum was carried out following treatment with BSS and lisinopril. Serum urea, creatinine and electrolytes were assayed using standard kit as tests for renal function, while alkaline phosphatase (ALP), aspartate transaminase (AST) and alanine aminotransferase (ALT) served as enzyme indices of the liver function. The effect on the serum lipid profile was assessed and histological examination performed on tissues of the liver and kidney.
RESULTS: The rats treated with BSS showed a significant decrease (p<0.05) in the serum creatinine concentration when compared with the hypertensive rats. Treatment with lisinopril showed a significant increase (p<0.05) in the activity of AST and ALP when compared with the normal rats. There were slight variations in the concentration of serum electrolytes of rats treated with BSS and lisinopril respectively when compared with normal and hypertensive rats. BSS significantly reduced calcium levels when compared with the hypertensive group. The histopathological examination of the liver and kidney of animals treated with BSS was not different from the control which showed normal histological structure, while the liver of the hypertensive animals showed scanty inflamed cells.
CONCLUSION: The study shows that BSS is effective in restoring basal liver and kidney functions in hypertensive rats.

Entities:  

Keywords:  biochemical indices; hypertension; lisinopril; β-sitosterol

Year:  2014        PMID: 26690542      PMCID: PMC4681395     

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  26 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  A rapid and precise method for the determination of urea.

Authors:  J K FAWCETT; J E SCOTT
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

Review 3.  Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia.

Authors:  P K Whelton; J He; P Muntner
Journal:  J Hum Hypertens       Date:  2004-08       Impact factor: 3.012

4.  Regarding the potential perils of phytosterols.

Authors:  Jon Brendsel; Shawn J Green
Journal:  Atherosclerosis       Date:  2006-09-18       Impact factor: 5.162

5.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

6.  Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial.

Authors:  Yasuhiko Homma; Ikuo Ikeda; Toshitsugu Ishikawa; Masao Tateno; Michihiro Sugano; Haruo Nakamura
Journal:  Nutrition       Date:  2003-04       Impact factor: 4.008

Review 7.  Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses.

Authors:  Robert A Moreau; Bruce D Whitaker; Kevin B Hicks
Journal:  Prog Lipid Res       Date:  2002-11       Impact factor: 16.195

8.  Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells.

Authors:  Atif B Awad; Rajat Roy; Carol S Fink
Journal:  Oncol Rep       Date:  2003 Mar-Apr       Impact factor: 3.906

9.  Interaction of cadmium with atrial natriuretic peptide receptors: implications for toxicity.

Authors:  J Giridhar; A Rathinavelu; G E Isom
Journal:  Toxicology       Date:  1992-11-01       Impact factor: 4.221

10.  Effect of dietary Garcinia kola seed on selected serum electrolytes and trace metals in male Albino rats.

Authors:  P O Agada; V B Braide
Journal:  Niger J Physiol Sci       Date:  2009-06
View more
  2 in total

Review 1.  The Genus Alternanthera: Phytochemical and Ethnopharmacological Perspectives.

Authors:  Rajeev K Singla; Vivek Dhir; Reecha Madaan; Deepak Kumar; Simranjit Singh Bola; Monika Bansal; Suresh Kumar; Ankit Kumar Dubey; Shailja Singla; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

2.  A β-Sitosterol Encapsulated Biocompatible Alginate/Chitosan Polymer Nanocomposite for the Treatment of Breast Cancer.

Authors:  Obaid Afzal; Md Habban Akhter; Irfan Ahmad; Khursheed Muzammil; Adam Dawria; Mohammad Zeyaullah; Abdulmalik S A Altamimi; Habibullah Khalilullah; Shehla Nasar Mir Najib Ullah; Mohammad Akhlaquer Rahman; Abuzer Ali; Naiyer Shahzad; Mariusz Jaremko; Abdul-Hamid Emwas; Ibrahim Abdel Aziz Ibrahim
Journal:  Pharmaceutics       Date:  2022-08-16       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.